Metabolic Syndrome and Symptom Burden in Allogeneic Hematopoietic Stem Cell Transplantation Survivors

Overview

Journal Future Oncol

Specialty Oncology

Date 2024 Nov 24

PMID 39580643

Authors

Jonathan Q Trinh

Jonathan D Nilles

Moataz Ellithi

Michael M Haddadin

Lori Maness-Harris

Krishna Gundabolu

Christopher S Wichman

Vijaya R Bhatt

Affiliations

Soon will be listed here.

Abstract

Introduction: Allogeneic hematopoietic stem cell transplantation (HCT) improves survival of patients with hematologic malignancies. A growing responsibility exists to identify and address long-term morbidity and symptom burden. We investigated metabolic syndrome and symptom burden in adult HCT survivors.

Methods: We analzyed adults with hematologic disorders who were treated with allogeneic HCT at our institution from June 2018-November 2022. We used standard criteria for metabolic syndrome with body mass index (BMI) as a surrogate for waist circumference. We assessed symptom burden using the National Comprehensive Cancer Network Survivorship Assessment. The Short Physical Performance Battery and Short Blessed Test were used to investigate physical function and cognition, respectively.

Results: A total of 152 patients were included. Median age was 61 years, 59% were male, and the most common disorder was acute myeloid leukemia (48%). 64 patients developed metabolic syndrome post-transplant. The most commonly affected symptom domains were fatigue (51%), sleep (45%), and cognitive function (42%). Additionally, 34% and 7% of patients had objectively impaired functional capacity and cognition, respectively.

Conclusion: Recipients of allogeneic HCT have a high incidence of metabolic syndrome, symptom burden, and impaired physical function.

References

Zhang M, Chen J, Yin Z, Wang L, Peng L . The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2021; 11(1):633. PMC: 8668963. DOI: 10.1038/s41398-021-01759-z. View

Jagasia M, Arora M, Flowers M, Chao N, McCarthy P, Cutler C . Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2011; 119(1):296-307. PMC: 3251233. DOI: 10.1182/blood-2011-06-364265. View

Welch S, Ward R, Beauchamp M, Leveille S, Travison T, Bean J . The Short Physical Performance Battery (SPPB): A Quick and Useful Tool for Fall Risk Stratification Among Older Primary Care Patients. J Am Med Dir Assoc. 2020; 22(8):1646-1651. PMC: 8113335. DOI: 10.1016/j.jamda.2020.09.038. View

Kanduri S, Cheungpasitporn W, Thongprayoon C, Bathini T, Kovvuru K, Garla V . Incidence and mortality of acute kidney injury in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. QJM. 2020; 113(9):621-632. PMC: 7828586. DOI: 10.1093/qjmed/hcaa072. View

Puthoff M . Outcome measures in cardiopulmonary physical therapy: short physical performance battery. Cardiopulm Phys Ther J. 2010; 19(1):17-22. PMC: 2845214. View

Norkin M, Hsu J, Wingard J . Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol. 2012; 49(1):104-9. DOI: 10.1053/j.seminhematol.2011.10.004. View

Pavasini R, Guralnik J, Brown J, Bari M, Cesari M, Landi F . Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis. BMC Med. 2016; 14(1):215. PMC: 5178082. DOI: 10.1186/s12916-016-0763-7. View

Bosnak Guclu M, Bargi G, Sucak G . Impairments in dyspnea, exercise capacity, physical activity and quality of life of allogeneic hematopoietic stem cell transplantation survivors compared with healthy individuals: a cross sectional study. Physiother Theory Pract. 2019; 37(1):52-63. DOI: 10.1080/09593985.2019.1594473. View

van Kraaij M, Dekker A, Verdonck L, van Loon A, Vinje J, Koopmans M . Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant. 2000; 26(3):299-303. PMC: 7091909. DOI: 10.1038/sj.bmt.1702484. View

10.

Rovo A, Tichelli A . Cardiovascular complications in long-term survivors after allogeneic hematopoietic stem cell transplantation. Semin Hematol. 2012; 49(1):25-34. DOI: 10.1053/j.seminhematol.2011.10.001. View

11.

DeFilipp Z, Duarte R, Snowden J, Majhail N, Greenfield D, Miranda J . Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant. 2016; 52(2):173-182. PMC: 5288134. DOI: 10.1038/bmt.2016.203. View

12.

Dirou S, Chambellan A, Chevallier P, Germaud P, Lamirault G, Gourraud P . Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017; 53(3):281-290. DOI: 10.1038/s41409-017-0057-5. View

13.

DeFilipp Z, Duarte R, Snowden J, Majhail N, Greenfield D, Miranda J . Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT. Biol Blood Marrow Transplant. 2016; 22(8):1493-1503. PMC: 4949101. DOI: 10.1016/j.bbmt.2016.05.007. View

14.

Majhail N, Flowers M, Ness K, Jagasia M, Carpenter P, Arora M . High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2008; 43(1):49-54. PMC: 2628412. DOI: 10.1038/bmt.2008.263. View

15.

Morris J, HEYMAN A, Mohs R, Hughes J, van Belle G, Fillenbaum G . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989; 39(9):1159-65. DOI: 10.1212/wnl.39.9.1159. View

16.

Saboya P, Bodanese L, Zimmermann P, Gustavo A, Assumpcao C, Londero F . Metabolic syndrome and quality of life: a systematic review. Rev Lat Am Enfermagem. 2016; 24:e2848. PMC: 5172619. DOI: 10.1590/1518-8345.1573.2848. View

17.

Busmail A, Penumetcha S, Ahluwalia S, Irfan R, Khan S, Rohit Reddy S . A Systematic Review on Pulmonary Complications Secondary to Hematopoietic Stem Cell Transplantation. Cureus. 2022; 14(5):e24807. PMC: 9170423. DOI: 10.7759/cureus.24807. View

18.

Jafari H, Jannati Y, Nesheli H, Hassanpour S . Effects of nonpharmacological interventions on reducing fatigue after hematopoietic stem cell transplantation. J Res Med Sci. 2017; 22:13. PMC: 5367206. DOI: 10.4103/1735-1995.199094. View

19.

Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J . Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009; 15(10):1143-238. PMC: 3103296. DOI: 10.1016/j.bbmt.2009.06.019. View

20.

Phelan R, Chen M, Bupp C, Bolon Y, Broglie L, Brunner-Grady J . Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. Transplant Cell Ther. 2022; 28(7):409.e1-409.e10. PMC: 9840526. DOI: 10.1016/j.jtct.2022.04.012. View